COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Antipsychotic Drugs and Their Side-Effects - 1st Edition - ISBN: 9780120790357, 9781483288109

Antipsychotic Drugs and Their Side-Effects

1st Edition

0.0 star rating Write a review
Editor: Thomas Barnes
Series Editor: Peter Jenner
eBook ISBN: 9781483288109
Imprint: Academic Press
Published Date: 8th November 1993
Page Count: 287
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

Basic Science: B.E. Leonard, The Pharmacology of the Phenothiazines, Butyrophenones, Thioxanthines, and Diphenylbutylpiperidines. D.M. Coward, The Pharmacology of Clozapine-Like Atypical Antipsychotics. J. Gerlach, Pharmacology and Clinical Properties of Selective Dopamine Antagonists, with Focus on Substituted Benzamides. J.L. Waddington, Pre- and Postsynaptic D-1 to D-5 Dopamine Receptor Mechanisms in Relation to Antipsychotic Activity. N.J. Rupniak and S.D. Iversen, Prediction of Antipsychotic Activity. P.J. Harrison, Effects of Neuroleptics on Neuronal and Synaptic Structure. P.F. Liddle, Brain Imaging and Antipsychotic Drugs. S.H. Curry, Pharmacokinetics of Antipsychotic Drugs. Clinical Issues: S.R. Hirsch, The Assessment of Antipsychotic Activity in Clinical Trials. R.G. McCreadie, Indications of Antipsychotic Drugs. J.M. Kane, Acute Treatment. J.M. Davis, P.G. Janicak, A. Singla, and R.P. Sharma, Maintenance Treatment. D.A.W. Johnson, Depot Neuroleptics. T.R.E. Barnes and J.G. Edwards, The Side Effects of Antipsychotic Drugs I: Neuropsychiatric Effects. J.G. Edwards and T.R.E. Barnes, The Side Effects of Antipsychotic Drugs II: Effects on Other Physiological Systems.


In line with other volumes in the Neuroscience Perspectives Series, this volume covers the background, pharmacology, molecular biology, and biochemistry of antipsychotic drugs, together with an overview assessment of the therapeutic considerations. Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including motor side-effects like parkinsonism. Studies show that lowering doses may still produce the antipsychotic effect while lessening the risk of side-effects. As all available antispychotic drugs are able to block dopamine, specifically D2 receptors, doses below the threshold level for producing acute motor disorder can still be therapeutically effective. With the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with better side-effect potential has arisen. Other novel antipsychotic agents include D1 receptor blockers, partial dopamine agonists and non-dopamine drugs such as 5-HT receptor blockers, sigma receptor antagonists and NMDA receptor agonists. This volume reviews both the basic science of the conventional and atypical neuroleptics and their present and potential therapeutic use.


Basic and clinical researchers in neuro- and psychopharmacology and neurosciences from academia and the pharmaceutical industry. May also be of interest to students in these fields.


No. of pages:
© Academic Press 1993
8th November 1993
Academic Press
eBook ISBN:

Ratings and Reviews

About the Editor

Thomas Barnes

Affiliations and Expertise

Charing Cross and Westminster Medical School, London, U.K.

About the Series Editor

Peter Jenner

Affiliations and Expertise

Division of Pharmacology and Therapeutics GKT School of Biomedical Sciences King’s College London SE1 1UL United Kingdom